SalvaRx Group PLC (LSE:SALV) - Share price - Overview

Stock Report

SalvaRx Group PLC SALV

Last Price
GBX29.25

Day Change
-1.75|-5.65%

As of 17/11/2017
10:29:24 GMT | GBX
Minimum 15 Minutes Delay.

Last Close31.00p
Day Range31.91 - 31.91
Mkt Cap10.67Mil
52-Wk Range27.00 - 46.80
Yield %0.00
ISINIM00BZ4SS228
Volume21,742
P/E11.89
P/SInfinity
P/CF-6.72

Share Price

Total Returns 22/11/2017

 Chg (%)  
More ...
SalvaRx Group PLC-6.40 
FTSE 100 TR GBP-1.04
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.00
Operating Profit0.00-0.19-2.48
Net Profit0.00-0.19-2.45
Reported EPS0.00-4.00-0.06
Balance Sheet
Current Assets1.441.001.00
Non Current Assets0.000.222.62
Total Assets1.441.223.62
Current Liabilities0.140.120.30
Total Liabilities0.140.121.19
Total Equity1.291.102.43
Cash Flow
Operating Cash Flow-1.49-0.30-1.51
Net Change in Cash-25.42-0.430.39
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Company Profile

SalvaRx Group plc is engaged in drug discovery and development, focused on immune-oncology. SalvaRx invests in novel cancer immuno-therapies and provides its portfolio companies with operational support.

Sector

Biotechnology

Market Position

1503 of 1833 Companies

Index

FTSE AIM All Share

Outlook

(27/09/2017) no outlook statement

Next Event 31/12/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)0.0013.5416.23
Div Yld (E)0.004.114.24
PEG (E)0.001.431.24
ROCE-75.11180.0915.44
Op Mrgn0.00-8.31-8.12
EPS Grwth0.0012.0813.42
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanJim Mellon
Chief Executive OfficerDr. Ian Walters
Chief Financial OfficerKam Shah
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.